You just read:

Real-World Data on XARELTO® in Patients with Non-Valvular Atrial Fibrillation and Diabetes Among 14 Presentations at American College of Cardiology's 65th Annual Scientific Session

News provided by

Janssen Pharmaceuticals, Inc.

21 Mar, 2016, 08:19 ET